I-123 iomazenil SPECT in patients with mental disorders

Annals of Nuclear Medicine

Volumn 11, Issue 4, 1997, Pages 339-344

  Nakabeppu, Yoshiaki ^a,b   Nakajo, Masayuki ^a   Naruo, Tetsuro ^a   Obo, Yoshihiko ^a   Nozoe, Shinichi ^b   Takigawa, Morikuni ^a   Tsuchimochi, Shinsaku ^a   Tani, Atsushi ^a   Tanaka, Hiromitsu ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

I 123 iomazenil; Mental disorder; SPECT; Washout ratio

Indexed keywords

BENZODIAZEPINE; BENZODIAZEPINE RECEPTOR; IOMAZENIL I 123; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG RECEPTOR BINDING; FEMALE; FRONTAL LOBE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; MENTAL DISEASE; PRIORITY JOURNAL; RADIOISOTOPE DISTRIBUTION; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EID: 0031418112     PISSN: 09147187     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03165304     Document Type: Article

References (14)

1. Beer HF, Blauenstein PA, Hasler PH, Delaloye B, Riccabona G, Bangerl I, et al. In vitro and in vivo evaluation of iodine-123-Ro 16-0154; a new imaging agent for SPECT investigations of benzodiazepine receptors. J Nucl Med 31: 1007-1014, 1990.
2. 123I]Ro 16-0154. Eur J Pharmacol 193: 249-252, 1991.
3. Innis RB, Al-Tikiriti MS, Zoghbi S, Baldwin RM, Sybirska EH, Laruelle MA, et al. SPECT imaging of the benzodiazepine receptor: feasibility of in vivo potency measurements from stepwise displacement curve. J Nucl Med 32: 1754-1761, 1991.
4. Feistel H, Kaschka WP, Ebert D, Koraschky P, Wolf F. Assessment of cerebral benzodiazepine receptor distribution in anxiety disorders - A study with I-123-IOMAZENIL. J Nucl Med 34: 47, 1993. (abstract)
5. 123I-IMP. Nippon Acta Radial 57: 41-46, 1997. (in Japanese)
6. Schlegel S, Steinert H, Bockisch A, Hahn K, Schloesser R, Benkert O. Decreased benzodiazepine receptor binding in panic disorder measured by IOMAZENIL-SPECT. A preliminary report. Eur Arch Psychiatry Clin Neurosci 244 (1): 49-51, 1944.
7. Kuikka JT, Pitkanen A, Lepola U, Partanen K, Vainio P, Bergstrom KA, et al. Abnormal regional benzodiazepine receptor uptake in the prefrontal cortex in patients with panic disorder. Nucl Med Commun. 16 (4): 273-280, 1995.
8. 123I-iomazenil: a new probe to evaluate central-type benzodiazepine receptor with SPECT. KAKU IGAKU (Jpn J Nucl Med) 32: 87-97, 1995. (in Japanese)
9. Onishi Y, Yonekura Y, Tanaka F, Nishizawa S, Okazawa H, Ishizu K, et al. Delayed image of iodine-123 iomazenil as a relative map of benzodiazepine receptor binding: the optimal scan time. Eur J Nucl Med 23: 1491-1497, 1996.
10. Benson DF. The Neurology of Thinking. 1st ed., New York: Oxford University Predss, 1994.
11. Mega MS, Cummings JL. Frontal-subcortical circuits and neuropsychiatric disorders. J Neuropsychiatry Clin Neurosci 6 (4): 358-370, 1994.
12. Goldman-Rakic PS. Working memory dysfunction in schizophrenia. J Neuropsychiatry Clin Neurosci 6 (4): 348-357, 1994.
13. Seidman LJ, Yurgelun-Todd D, Kremen WS, Woods BT, Goldstein JM, Faraone SV, et al. Relationship of prefrontal and temporal lobe MRI measures to neuro-psychological performance in chronic schizophrenia. Biol Psychiatry 35 (4): 235-246, 1994.
14. 123I]iomazenil SPECT imaging demonstrates significant benzodiazepine receptor reserve in human and nonhuman primate brain. Neuropharmacology 32: 671-680, 1993.